Status:
COMPLETED
Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD
Lead Sponsor:
Gregory Fabiano
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
16-25 years
Phase:
PHASE4
Brief Summary
There has been little research on the third area of impairment noted in the Diagnostic and Statistical Manual of Mental Disorders - "occupational functioning." Individuals with ADHD experience job-rel...
Eligibility Criteria
Inclusion
- diagnosis of ADHD
- parental permission and/or teen consent/assent as appropriate
- between 16-25 years of age
- IQ greater than or equal to 70
- permit or license to drive
- ability to read and understand English
Exclusion
- any medical condition that would contraindicate use of stimulant medication
- any prior adverse response to lisdexamfetamine dimesylate or other stimulant medication
- use of concurrent,non-stimulant psychoactive medication
- diagnosis of schizophrenia or presence of thought disorder symptoms
- autism spectrum disorder
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03446885
Start Date
April 1 2018
End Date
August 30 2019
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SUNY at Buffalo
Buffalo, New York, United States, 14214